ecrin-mdr-crcClinical2011Colorectal CancerColorectal NeoplasmsColorectal CancerColorectal NeoplasmsObservationalhttps://newmdr.ecrin.org/Study/2113422Slovakia10OxaliplatinCapecitabineAdjuvant settingECRIN MDRCompletedfalseAn Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon CancerThis observational study evaluates the efficacy and safety of capecitabine in combination with oxaliplatin in the adjuvant setting in participants with Stage III colon cancer. Data were collected from each participant for up to 36 months or until disease recurrence.2011-10-152113422NCT01442155